JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1951
CALL
Entegris
ENTG
$25.5B
| $13.1M | ﹤0.01% |
200,000
+152,700
| +323% | +$11.2M |
2022 Q3
1 quarter
|
|
|
MGI
1952
DELISTED
MoneyGram International, Inc. New
MGI
| $13.1M | ﹤0.01% |
1,202,507
+596,020
| +98% | +$6.38M |
2020 Q2
10 quarters
|
|
|
MNK
1953
DELISTED
Mallinckrodt plc
MNK
| $13.1M | ﹤0.01% |
+1,686,088
| New | +$18.9M |
2022 Q4
0 quarters
|
|
1954
PUT
Deutsche Bank
DB
$65.7B
| $13.1M | ﹤0.01% |
1,133,700
-1,299,000
| -53% | -$12.8M |
2022 Q1
3 quarters
|
|
1955
Enterprise Financial Services Corp
EFSC
$2.17B
| $13.1M | ﹤0.01% |
266,709
+4,177
| +2% | +$207K |
2013 Q2
38 quarters
|
|
1956
Pricesmart
PSMT
$5.3B
| $13M | ﹤0.01% |
213,946
-107,402
| -33% | -$7.01M |
2015 Q4
28 quarters
|
|
1957
Marcus Corp
MCS
$822M
| $13M | ﹤0.01% |
901,157
+54,253
| +6% | +$822K |
2016 Q1
27 quarters
|
|
1958
Unitil
UTL
$924M
| $13M | ﹤0.01% |
252,482
+18,680
| +8% | +$950K |
2013 Q2
38 quarters
|
|
1959
CALL
CVS Health
CVS
$111B
| $13M | ﹤0.01% |
139,000
| – | – |
2021 Q2
6 quarters
|
|
|
PRFT
1960
DELISTED
Perficient Inc
PRFT
| $12.9M | ﹤0.01% |
185,354
-25,023
| -12% | -$1.73M |
2016 Q1
27 quarters
|
|
1961
Axsome Therapeutics
AXSM
$9.28B
| $12.9M | ﹤0.01% |
167,577
-4,301
| -3% | -$257K |
2019 Q2
14 quarters
|
|
1962
Westlake Corp
WLK
$8.26B
| $12.9M | ﹤0.01% |
126,044
+6,736
| +6% | +$679K |
2013 Q2
38 quarters
|
|
1963
Ormat Technologies
ORA
$5.61B
| $12.9M | ﹤0.01% |
149,158
-168,475
| -53% | -$15.1M |
2014 Q4
32 quarters
|
|
|
VRTV
1964
DELISTED
VERITIV CORPORATION
VRTV
| $12.9M | ﹤0.01% |
105,854
-71,200
| -40% | -$8.62M |
2014 Q3
33 quarters
|
|
1965
CALL
Intuitive Surgical
ISRG
$144B
| $12.9M | ﹤0.01% |
48,500
+8,600
| +22% | +$2.1M |
2017 Q2
22 quarters
|
|
1966
Donnelley Financial Solutions
DFIN
$1.19B
| $12.9M | ﹤0.01% |
332,487
+357
| +0.1% | +$13.4K |
2016 Q4
24 quarters
|
|
1967
Steven Madden
SHOO
$3.34B
| $12.8M | ﹤0.01% |
402,008
+41,120
| +11% | +$1.29M |
2013 Q2
38 quarters
|
|
1968
PennyMac Financial
PFSI
$3.27B
| $12.8M | ﹤0.01% |
226,459
+53,180
| +31% | +$2.82M |
2014 Q3
33 quarters
|
|
1969
WSFS Financial
WSFS
$3.95B
| $12.8M | ﹤0.01% |
282,791
+38,369
| +16% | +$1.8M |
2013 Q2
38 quarters
|
|
1970
Ashland
ASH
$3.15B
| $12.8M | ﹤0.01% |
119,123
-10,219
| -8% | -$1.08M |
2013 Q2
38 quarters
|
|
|
HEP
1971
DELISTED
Holly Energy Partners, L.P.
HEP
| $12.8M | ﹤0.01% |
706,684
-157,021
| -18% | -$2.87M |
2013 Q2
38 quarters
|
|
1972
EPR Properties
EPR
$4.26B
| $12.8M | ﹤0.01% |
338,149
-22,503
| -6% | -$876K |
2013 Q2
38 quarters
|
|
1973
Mueller Water Products
MWA
$3.4B
| $12.7M | ﹤0.01% |
1,181,487
+425,299
| +56% | +$4.74M |
2013 Q2
38 quarters
|
|
|
NUVL
1974
DELISTED
Nuvalent
NUVL
| $12.7M | ﹤0.01% |
426,426
+335
| +0.1% | +$9.34K |
2021 Q3
5 quarters
|
|
|
VIVO
1975
DELISTED
Meridian Bioscience Inc
VIVO
| $12.7M | ﹤0.01% |
381,880
+180,797
| +90% | +$5.82M |
2015 Q3
29 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.